News
I celebrated five years since my bone marrow transplant with a surprise video from my donor, a beautiful reminder of the life ...
18h
TipRanks on MSNMoleculin Biotech Gains Approval for Phase 2B/3 AML StudyAn announcement from Moleculin Biotech ( ($MBRX) ) is now available. On July 9, 2025, Moleculin Biotech announced that the Regulation Agency for ...
Moleculin Biotech (MBRX) announced that the Regulation Agency for Medical and Pharmaceutical Activities, or RAMPA, in the country of Georgia has ...
Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results